Treatment of type 2 diabetes

US8202884B2 · kind B2 · utility

Assignee

• Neurosearch A/S · DK

Inventors

• Klaus Dugi · Dresden, DE
• Andreas Raschig · Biberach, DE
• Juergen Reess · Ulm, DE
• Frank Berger · Leutenbach, DE
• Laurence Salin · Mougins, FR

Key dates

• Filing date: Oct 31, 2006
• Grant date: Jun 19, 2012
• Expiry date: Oct 4, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.